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Abstract
Background: It is well established that low levels of 25(OH) Vitamin D (,30 ng/dL) are a common finding world over,
affecting over a billion of the global population. Our primary objective was to determine the prevalence of vitamin D
deficiency and insufficiency in the asymptomatic adult population of Karachi, Pakistan and the demographic, nutritional and
co-morbidity characteristics associated with serum vitamin D levels.
Methods: A cross-sectional population survey was conducted at two spaced out densely populated areas of the city. Serum
levels of 25OHVitamin D were measured and GFR as renal function was assessed by using 4 variable MDRD formula.
Results: Our sample of 300 had a median age of 48(interquartile range 38–55) years. The median level of serum vitamin D
was 18.8 (IQ range 12.65–24.62) ng/dL. A total of 253 (84.3%) respondents had low levels (,30 ng/dL) of 25OH vitamin D.
Serum PTH and vitamin D were negatively correlated (r =20.176, p = 0.001). The median PTH in the vitamin D sufficiency
group was 38.4(IQ range28.0–48.8)pg/mL compared with 44.4(IQ range34.3–56.8) pg/mL in the deficiency group
(p = 0.011).The median serum calcium level in the sample was 9.46(IQ range 9.18–9.68) ng/dL. Low serum levels of vitamin D
were not associated with hypertension (p = 0.771) or with an elevated spot blood pressure (p = 0.164).In our sample 75(26%)
respondents had an eGFR corresponding to stage 2 and stage 3 CKD. There was no significant correlation between levels of
vitamin D and eGFR (r =20.127, p-value = 0.277).Respondents using daily vitamin D supplements had higher 25 OH vitamin
D levels (p-value = 0.021).
Conclusion: We observed a high proportion of the asymptomatic adult population having low levels of vitamin D and
subclinical deterioration of eGFR. The specific cause(s) for this observed high prevalence of low 25OH vitamin D levels are
not clear and need to be investigated further upon.
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Introduction
Vitamin D is one of the major players involved in calcium
homeostasis in the human body. It has been shown that sufficient
serum levels of vitamin D are needed for bone health and
development. Vitamin D deficiency has been associated with
development of osteoporosis due to induction of secondary
hyperparathyroidism, which mobilizes calcium out of bones
increasing the risk of fall related fractures especially in the elderly
[1]. Other then decreased bone mineral density vitamin D
deficiency can present as rickets and osteomalacia, in the pediatric
and adult population respectively[2]. It has also been associated
with myopathy and may hold key while addressing to unexplained
aches and pains presentations in the outpatient setting [3].
Along with its proven beneficial role in bone mineralization, the
vitamin has been described as having ‘steroid like action’ as it
regulates the function of over two hundred genes [4]. Recent
evidence has shown that vitamin D has a role as an immune
modulator and tumor suppressor [5,6,7]. It has been proposed that
this vitamin may help in prevention of chronic diseases including
type 1 diabetes mellitus, coronary heart disease, multiple sclerosis,
rheumatoid arthritis and cognitive impairment [8,9,10,11,12,
13,14].
Low levels of vitamin D (,30 ng/dL) is a common finding
world over [15,16] and varies depending on the population
studied, adherence to food fortification policies, demographic
features, geographic location and season. It has been estimated
that over one billion people globally have low serum vitamin D
levels [17]. Majority of individuals with vitamin D deficiency/
insufficiency are asymptomatic–making it a difficult clinical entity
to detect. According to the clinical practice guidelines on vitamin
D issued by Endocrine Society [18], vitamin D deficiency has been
defined as serum 25(OH) vitamin D levels less than 20 ng/dL
whereas insufficiency constitutes serum 25(OH) vitamin D levels
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between 20 ng/dL and 30 ng/dL. Serum levels greater than
30 ng/dL are deemed sufficient for children and adults.
25(OH) vitamin D is used as the marker of vitamin D status in
the body, rather than 1, 25(OH) vitamin D which represents the
active metabolite of vitamin D. Low levels of 1, 25(OH) vitamin D
is an expected and commonly seen phenomenon in chronic kidney
disease patients due to decreased 1-alpha hydroxylase activity,
however the effect of CKD on levels of 25(OH) D is not as yet
clear. A high prevalence of 25(OH)D deficiency has been observed
in CKD patients in numerous studies and it has been seen that
25(OH) vitamin D deficiency worsens with progression of CKD,
due to compromise in denovo synthesis of precursors of 25(OH) D
[19,20,21]. Ravani ET. al. observed that 25(OH)D and plasma
phosphate were independent predictors of renal disease progres-
sion and death in CKD patients [8].
The reported prevalence of low levels of vitamin D (,30 ng/
dL) in our region ranges from 85–98%, as observed by numerous
authors. A cross sectional study done in Karachi Pakistan, on
employees in a tertiary care center revealed 90% of the employees
having low vitamin D levels [17]. A 92% prevalence of vitamin D
deficiency is reported by Zuberi et. al. in retrospectively studied
asymptomatic ambulatory patients presenting to the endocrinol-
ogy outpatient service in a tertiary care center in Karachi [22].
Similarly studies done in neighboring India report the prevalence
of low levels of vitamin D to be ranging between 80–85% in
groups of postmenopausal women and local hospital staff [23,24].
Prevalence of Vitamin D deficiency and insufficiency was found
out to be 80% in healthy adults living in urban Tehran, Iran [25].
Most of the published literature on Vitamin D levels in Pakistan
is performed in smaller outpatient settings or single centers,
involving specific groups and pockets of the population. There is a
dearth of published data on prevalence of vitamin D deficiency in
asymptomatic population of urban centers, such as Karachi.
Therefore giving us a rationale to conduct a cross sectional study
in densely populated areas of urban Karachi with the primary
objective to estimate the prevalence of vitamin D deficiency and
insufficiency in the asymptomatic population along with observing
the associations between serum 25(OH) vitamin D levels and
demographic, nutritional and co-morbidity characteristics of the
population studied. Another aim of our study is to find any
association of vitamin D levels with e GFR and CKD status. Since
it has been seen that CKD may be a risk factor for vitamin D
deficiency and that vitamin D deficiency is a predictor for renal
disease progression in CKD, we tried to look at any associations
between vitamin D status and eGFR in asymptomatic adults with
subclinical deterioration in kidney function.
Methods
Ethics statement
Study methodology was approved by the Ethical review
committee of the Aga Khan University(ERC protocol-1628).
Informed consent was taken from respondents by means of an
informed consent form. Participants were informed regarding their
laboratory results by means of postal service.
Setting
The study was conducted as a cross-sectional study, set in
urban metropolis of Karachi (24u53 N and 67u00 E) - the largest
city of Pakistan during the period of January 2011. The survey
was performed by establishing medical camps, in a time span of
three weeks, at two city shopping centers-Defence Sunday Market
and Gulshan-e-Iqbal Friday market. These centers were identi-
fied due to their central location and variability of attendees from
diverse socioeconomic background. A high population density
and ethnic diversity within the corresponding areas make both of
these sites good representatives of the general adult population of
the city. All participants were recruited after taking formal
informed consent. A pamphlet briefly describing the function of
vitamin D along with its sources and study objectives was
distributed in the area to inform people about the research
objective of the survey.
Sample Size
Keeping in view the primary aim of our study, to find the
prevalence of vitamin D deficiency and insufficiency in asymp-
tomatic population of an urban centre, the sample size was
calculated using the Sample Size Determination in Health Studies
software provided by the World Health Organization. The
reported collective prevalence of vitamin D insufficiency and
deficiency in our region is between 85–98%. . Using an anticipated
population proportion of 85%, a relative precision of 0.05 with
95% confidence–the sample size calculated was 272, which
allowed us to estimate the prevalence of low levels of vitamin D
to within 5% of the true value with 95% confidence. Participation
of both literate and illiterate asymptomatic adults was ensured by
sending medical students and assistants into the market to inform
and explain the purpose of the camp and also through posters and
pamphlets printed in local language. Asymptomatic healthy
respondents between 30–80 years of age were recruited.
Individuals with signs and symptoms of hypo-calcemia, pregnant
and nursing mothers and those with diagnosed metabolic bone
diseases were not included. By conducting this study in a market
setting the house bound and less mobile members of the
community were not included since housebound adults cannot
come to the market locations because of their co-morbidity status
or physical disability. Therefore our methodology enabled us to
exclude the less mobile, house bound, ill patients and the results
reflect vitamin D levels in apparently healthy asymptomatic adults,
as per objective of the study.
Data Collection
The initial stage of assessment involved administration of an
interview based questionnaire, at the site of camp. The
interviewers, comprising of two medical students and a single
research assistant at home university, were trained and briefed
prior to taking the interviews, for the purpose of consistency in
data collection. The questionnaire recorded information on age,
level of education(degree obtained at last year of school or college),
monthly gross income, co-morbidity status(such as diabetes
mellitus, hypertension and Ischemic heart disease), diet pattern(in-
cluding daily milk intake per 250 mL servings), sun exposure
(approximate number of minutes per day spent in sunlight) and
medication use including oral vitamin D supplementation. The
physical assessment performed by the same interviewer included a
blood pressure check and anthropometric measurements with a
balance scale and stadiometre. Hypertensive respondents in the
study are defined as those with a prior diagnosis of hypertension
and/or those taking pharmacotherapy to control blood pressure.
An elevated spot blood pressure is defined as a one time systolic
reading$140 mm of Hg and diastolic$90 mm of Hg, the cut offs
were adjusted in diabetics and CKD patients in accordance with
the JNC-7 guidelines. Since the study was conducted in a winter
month most of the participants, both males and females, were
present in the traditional winter dress covering all the body except
the face and hands, therefore no objective assessment of covering
was made.
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Blood samples
Venous blood samples of 10 cm3 were collected by two expert
phlebotomists in three plastic serum tubes for each respondent.
The samples were placed in ice boxes at the site of the camp and
were sent to the lab in batches. There was a time lag of
approximately 60 minutes between venous puncture and serum
separation after centrifugation at 3000 bpm. After centrifugation
the serum was stored in the laboratory freezer at 220uC, until
further analysis. Serum markers measured included 25(OH)
vitamin D, intact parathyroid hormone (PTH), calcium (Ca),
albumin, creatinine (Cr), phosphorus, and alkaline phosphatase
(AP). Measurement of serum levels of 25(OH) vitamin D was
done by radioimmunoassay technique with Diasorin SRH kits
being used. The venous blood samples for PTH analysis were
collected in EDTA plasma collection tubes. We were mindful of
the implications of time delay and confident that the time lag of
approximately one hour between sample collection and comple-
tion of centrifugation, allowed for accurate PTH measurements
using the DPC(Diagnostic Product Corporation) ImmuliteH
assay.
Calculations
Renal eGFR was calculated for 288 subjects, by the four
variable MDRD formula using the investigated level of serum
creatinine and patient anthropometric measurements as taken
during the physical assessment. CKD stages were defined,
following the National Kidney Foundation clinical practice
guidelines.
Data Entry and Analysis
The data was entered into a pre-designed data base by two
individuals separately using Epi Data Version 3.6.1. Both data sets
where then checked to detect any errors in data entry and all
discrepancies during data entry, were rectified using the hard copy
of the filled questionnaires and laboratory data. The data was
analyzed using Statistical Package for Social Sciences version 17
(SPSS v.17.0H).
In uni-variate analysis, descriptive statistics were used to look at
the spread of data with respect to the age, education and economic
status. Proportion & percentages were computed for categorical
variables. Tests for normality, including the Shapiro Wilk test,
were used to check for normality assumption for continuous
variables. Due to the asymmetric distributions of the outcome
variable of vitamin D levels along with other biochemical markers
and presence of atypical values (outliers), parametric tests
including linear analysis of variance (ANOVA) and linear
regression tests were not used. The median and inter-quartile
range was used to describe the sample.
The variable of serum vitamin D level was divided into three
categories of deficiency, insufficiency and sufficiency, for the
purpose of bi-variate analysis. Chi square test was used to find any
associations between groups of vitamin D levels and other
categorical variables. Non parametric tests including the Krus-
kal-Wallis test and Mann Whitney U test were conducted to find
any significant difference in continuous variables between groups
of the vitamin D levels. Continuous relationships of 25(OH)
vitamin D levels with various patient characteristics including
gender, hypertension status, CKD stage, milk intake and sunlight
exposure were investigated using the Mann Whitney U and
Kruskal Wallis test. Spearman’s rank correlation was applied to
determine associations of vitamin D levels with other serum
biochemical markers and eGFR. A p-value of ,0.05 was taken to
be statistically significant.
Results
Our sample of 300 comprised of 194(65%) males respondents.
The median age of the sample was 48 (interquartile range 38–55)
years. The minimum age in the sample was 30 years, with a
maximum age of 80 years being reported. The respondents came
from diverse educational backgrounds with 23.4% holding
intermediate (2 years of college) degree and 14% having no
formal education at all. The median gross monthly income was
USD $172(interquartile range $ 115–344). Table 1 summarizes the
sample characteristics as seen in each of the groups of vitamin D
deficiency, insufficiency and sufficiency.
The median level of serum 25(OH) vitamin D was 18.8(inter-
quartile range 12.65–24.62) ng/dL, with sample vitamin D levels
ranging from 5.23 to 56.32 ng/dL. A total of 253 (84.3%)
respondents had low (,30 ng/dL) levels of vitamin D, comprising
of 173(57.7%) respondents in the vitamin D deficiency group. In
terms of gender, the median serum vitamin D levels in male
respondents came out to be 18.99(interquartile range 12.28–
24.41)ng/dL compared to 18.18(interquartile range 13.36–
25.00)ng/dL in females. Eighty six percent of the men and 82%
of the females were found to have serum 25(OH) vitamin D levels
less than the 30 ng/dL cut off for vitamin D sufficiency. Looking
at continuous relationships, vitamin D levels in the sample were
not significantly different between males and females (p = 0.994).
Vitamin D deficiency was more frequently observed in females
(62.3%) than in men(55.2%), however this difference was not
statistically significant(p = 0.134).The distribution of vitamin D
levels in the sample have been shown in Figure 1.
The PTH levels ranged from 11 pg/mL to 146 pg/mL. A
significant negative correlation was observed between vitamin D
levels and PTH levels (r =20.176, p = 0.001), as shown in figure 2.
A statistically significant difference was seen in the median PTH
levels, when the group of vitamin D sufficiency was compared with
the deficiency group (p = 0.011).However there was no significant
difference between the sufficiency and insufficiency groups
(p = 0.600). Hyper-parathyroidisim (PTH.87 pg/mL) was seen
in 14 individuals (4.7%) having a median 25OH vitamin D level of
17.3 (interquartile range 9.78–27.67) ng/dL. Out of the 14
individuals with hyperparathyroidism, nine respondents were
found to be having deficient levels of vitamin D with a median
serum vitamin D level of 11.35 (interquartile range 9.05–17.30)
ng/dL.
The median serum calcium level observed was 9.46 (inter-
quartile range 9.18–9.68) ng/dL. There was no significant
difference in serum calcium levels when the vitamin D sufficiency
group was compared with deficiency and insufficiency groups
(p = 0.636, 0.125 respectively). Serum phosphate levels of lower
than 2.5 mg/dL were seen in 41(13.6%) respondents. An elevated
phosphate level (.4.5 mg/dL) was seen in four (1.3%) respon-
dents, with all four having vitamin D levels of less than 30 ng/mL.
In terms of calculated GFR we observed no significant
correlation with vitamin D levels (r =20.127, p= 0.277) or
difference when the group of vitamin D sufficiency was compared
with the insufficiency and deficiency groups (p = 0.316, 0.096
respectively).The continuous relationship between vitamin D and
eGFR is shown in figure 3. On the basis of eGFR, no CKD was
seen in 213 respondents (75%), 61(21%) respondents had an
eGFR corresponding to stage 2 CKD and 14 respondents (5%)
had eGFR corresponding to stage 3 CKD. There was no
statistically significant difference in the median 25(OH) vitamin
D levels between respondents in the three CKD stage groups
(p = 0.127).In the vitamin D deficiency group 41 (24%) respon-
dents with vitamin D deficiency had an eGFR corresponding to
Vitamin D Levels in Karachi
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stage 2 and stage 3 CKD, compared to 16(20%) and 18(38%)
respondents from the insufficiency and sufficiency group respec-
tively. As observed 75(25%) respondents had a GFR,90 mL/min
per 1.73 m2, corresponding to CKD stages 2 and 3, this is in stark
contrast with the 7(2.3%) respondents reporting co-morbidity with
CKD at the time of questionnaire administration.
Hypertension status had no significant association with vitamin
D levels since there was no statistically significant difference in
vitamin D levels when respondents with and without hypertension
were compared(p = 0.771). Similarly we saw no association
between an elevated spot blood pressure and vitamin D levels
(p = 0.164).At the time of assessment 78(26%) respondents
reported a co-morbidity with hypertension out of which 53(18%)
were taking antihypertensive medication. An elevated spot blood
pressure was observed in 97 (32%) respondents, out of which
22(23%) respondents were taking antihypertensive medication
while 61(63%) respondents with an elevated spot blood pressure
had no prior diagnosis of hypertension. At least one daily milk
serving (250 ml) and daily sunlight exposure greater than
30 minutes were not found to have an significant association with
vitamin D levels, as depicted by p-values of 0.618 and 0.279,
respectively.
The regular use of oral vitamin D containing supplements on a
daily basis was significantly associated with vitamin D levels
(p = 0.021).In the vitamin D deficiency group, it was observed that
only 36(21%) respondents used vitamin D containing supplements
compared to 19(40%) in the sufficiency group. Overall in the
sample of 300, only 74(24.7%) respondents reported use of oral
vitamin D containing supplements with 59(19.6%) respondents
taking one dose on a daily basis.
Discussion
As seen in our study low levels of vitamin D (,30 ng/dL) were
present in 84.3% of the general population with both genders
affected equally. This finding, although expected, in itself is very
significant and considering the fact that our study sample
comprised of asymptomatic adults in the community, it does raise
Table 1. Sample characteristics with respect to Vitamin D groups.
Deficiency (n =173) Insufficiency (n =80) Sufficiency (n=47) p-value
Age(years) 47.0 (35.0–54.0) 48.0 (39.5–56.5) 52.0 (40.8–64.2) 0.021
Gender 0.134
Male(n =194) 107(55.2%) 59(30.4%) 28(14.4%)
Female(n =106) 66(62.3%) 21(19.8%) 19(17.9%)
Median Vitamin D levels (ng/dL) 13.4 (9.9–17.1) 23.5 (21.6–25.6) 34.9 (32.9–41.8) 0.001
BMI (kg/m2) 27.4 (24.8–30.8) 26.7 (23.9–30.1) 26.5 (23.9–29.9) 0.326
PTH (pg/ml) 44.4 (34.3–56.8) 35.6 (26.9–43.9) 38.4 (28.0–48.8) 0.001
Calcium(mg/dl) 9.46 (9.24–9.67) 9.44 (8.92–9.68) 9.49 (9.23–9.71) 0.189
Phosphorus(mg/dl) 3.14 (2.71–3.43) 3.08 (2.88–3.45) 3.18 (2.78–3.61) 0.846
Albumin (g/dl) 4.92 (4.73–5.06) 4.89 (4.57–5.05) 4.80 (4.56–4.97) 0.100
Alkaline Phosphate (U/L) 91 (79–106) 95 (74–108) 97 (72–116) 0.819
Creatinine (mg/dl) 0.77 (0.67–0.86) 0.78 (0.67–0.93) 0.77 (0.66–0.97) 0.370
eGFR (ml/min per 1.73 m2) 105.8 (90–119) 101.7 (90–121) 103.0 (82–116) 0.234
Diagnosed CKD(n =7) 4 (57.1%) 1 (14.3%) 2 (28.6%) 0.556
Hypertension(n=78) 45 (57.5%) 19 (24.4%) 14 (17.9%) 0.755
High spot Bp(n =97) 62 (63.9%) 27 (27.8%) 8 (8.2%) 0.078
Diabetes Mellitus(n =89) 54 (60.7%) 19 (21.3%) 16 (18.0%) 0.373
Vitamin D Supplement use(n =74) 36 (48.6%) 19 (25.7%) 19 (25.7%) 0.021
Daily sunlight .30 mins(n =239) 143 (59.8%) 57 (23.8%) 39 (16.3%) 0.092
Median values and inter quartile ranges are reported.
doi:10.1371/journal.pone.0033452.t001
Figure 1. Distribution of 25(OH) vitamin D.
doi:10.1371/journal.pone.0033452.g001
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a health care concern that a sizeable majority of the healthy
population is deprived of the proven benefits of vitamin D. The
overall figure of 84.3% respondents having low vitamin D levels is
comparable to findings reported by other studies done in Karachi
on vitamin D levels, however we observed that 15.7% of
respondents had sufficient levels(.30 ng/dL) of vitamin D
compared to 8.9% and 8.0% reported previously by Mansoor
et al. and Zuberi et al. respectively [17,22]. The larger size of the
sufficiency group as seen in our results may be explained by the
difference in study setting, with both the above mentioned studies
being conducted in a hospital setting in contrast to the community
setting employed in our study. In our study, 57.7% of the
Figure 2. Scatter plot showing negative correlation between vitamin D and PTH.
doi:10.1371/journal.pone.0033452.g002
Figure 3. Scatter plot between vitamin D and Egfr.
doi:10.1371/journal.pone.0033452.g003
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respondents had vitamin D deficiency(,20 ng/dL), this is lower
than 79.6% and 69.0% prevalence of vitamin D deficiency
reported in studies conducted on general asymptomatic population
in Tehran [25] and Tripurti, South India [26] respectively. Again
these differences in results from regional studies prove even though
vitamin D deficiency is prevalent region wide, the proportion of
population affected varies.
Despite the observational nature of our research and inability to
identify predictors of vitamin D status, we feel it is important to
discuss the possible causes of low vitamin D levels seen in the
majority of our sample. Amongst dietary factors contributing to
low vitamin D levels is the lack of a food fortification policy in
Pakistan and a traditional diet lacking in vitamin D. More over the
beneficial role of vitamin D supplementation is underutilized in
the community as only 74(24.7%) respondents reported use in our
results. Darker skin pigmentation has also been associated with
decreased skin synthesis of vitamin D [4,27] as have been habits of
betel and areca nut chewing [28] which is a common practice in
Karachi specifically, though these factors have not been accounted
for by our study.
The blood samples were taken in the month of January, which
corresponds to winter season in Karachi. The average day length
in January has been estimated to be 10.6 hours compared to
13.5 hours in May. Also the average total monthly sunshine hours
in Karachi, during January (271 hours), is less than the summer
months of April (282 hours) and May (304 hours). Keeping in
view the shorter day length and decreased number of total
sunshine hours, it can be logically concluded that respondents in
Karachi have lower sun exposure in January as compared to the
summer months. The seasonal variation in levels of serum 25OH
vitamin D due to the differences in sunlight exposure was studied
by Goswami et. al in a prospective study done in Delhi, which
showed that the study group had significantly higher 25 OH
vitamin D levels in summer as compared to the winter assessment
[29]. Similarly Azizi et. al. found out that vitamin D sufficiency
was a more frequent finding in the summer months than in winter,
amongst the working male population of Tel Aviv, Israel [30].
Therefore low sun exposure in January and preceding winter
months, may explain the high proportion of respondents having
vitamin D deficiency (57.7%) and insufficiency (26.6%) we see in
our study.
In our results, vitamin D was negatively correlated to PTH
levels (r =20.176) and the PTH levels were significantly higher in
the vitamin D deficiency group when compared with the
sufficiency group. Despite a high number of individuals being
deficient in vitamin D(57.7%), the number of respondents having
hyperparathyroidism(4.7%) was less than expected-this observa-
tion is in contrast to the results seen by various authors
[17,22,25,31]. Although, secondary hyperparathyroidism has
often been used a marker for vitamin D deficiency [32] in our
study this was not observed. This may be explained by the fact that
13.6% of the sample had low phosphate levels. Serum phosphate
has been found to have a direct effect on PTH secretion,
independent of ionized calcium and 1,25(OH)vitamin D, via post-
transcriptional mechanisms [33]. Therefore low serum phosphate
levels may have been a cause for decreased stimulus for PTH
secretion and hence the lesser number of respondents with
secondary hyperparathyroidism.
The favorable effects of vitamin D supplementation have been
documented by Pelicane et. al. [34] in a retrospective study and
were also seen in our study with 40% of the respondents in the
sufficiency group reporting use of vitamin supplements containing
vitamin D compared with only 21% in the deficiency group. In
contrast to our findings in the general population Thomas et. al.
found multivitamin therapy was not protective against hypo-
vitaminosis D in medical inpatients [35], however the study being
mentioned was done in a setting of acutely ill patients. According
to the 2011 Institute of Medicine (IOM) report, the recommended
daily intake for vitamin D, for adults between 19–70 years of age is
600 IU/day for achieving adequate bone health. There is still
debate on whether the daily intake should be increased to 1500–
2000 IU/day to maintain serum 25(OH) vitamin D levels above
the desired 30 ng/dL mark [18]. Similarly with increasing age and
in countries where sun exposure is inadequate the recommended
intake should be a minimum of 800–1000 IU/day [36].
Considering the fact that the daily requirement for vitamin D is
barely met by dietary intake and limited sun exposure, the need
and benefit of supplementation is well established in international
literature, but no local or regional guidelines are available on the
subject.
Chronic kidney disease patients have a higher propensity for
developing 1,25(OH)vitamin D deficiency and it is almost a
universal finding in patients with end stage renal disease [8,37].
There have also been findings of an increased mortality risk in
advanced CKD patients having deficient serum levels of 25(OH)
vitamin D [38]. In our study no correlation was seen between
estimated GFR and serum vitamin D levels, this could be due to
the reason that we did not measure serum 1,25(OH) vitamin D
levels. The more surprising finding was that 25% of the study
population had an estimated GFR corresponding with CKD stage
2 and stage 3.Viewing this with the fact that only 2.3% of the
sample reported of a co-morbidity with CKD, we feel that future
studies that assess sub-clinical deterioration of renal function in
natives of this region are warranted.
Conclusion
We observed a high proportion of the asymptomatic general
population having low levels of vitamin D and subclinical
deterioration of eGFR. The possible causes of low levels of serum
25OH vitamin D seem to be multiple and need to be investigated
in further detail in order to address this public health concern.
Limitations of study
Our inability to draw a random sample may reduce the
generalize-ability of results. Since the difference between demo-
graphics and co-morbidity status of asymptomatic responders and
non responders is not known, there is a potential for a selection
bias. The cross sectional design of our study with a single blood
sample collection in a winter month, having low sun exposure, and
application of non parametric analysis proves to be a limitation in
drawing concrete conclusions about a population therefore a
longitudinally designed research proposal with serial blood
sampling performed in both the winter and summer months is
recommended. Increasing sample size with inclusion of more
pockets of population including rural population would help in
generalize ability.
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